Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study

Abstract Background Probiotics have been shown to be useful for the treatment of many disease conditions. These beneficial effects are believed to be mediated by change in the composition of gut microbiota and modulation of the host immune responses. However, the available data on the effect of prob...

Full description

Bibliographic Details
Main Authors: Ankita Singh, Aditya N. Sarangi, Amit Goel, Rajni Srivastava, Rajat Bhargava, Priyanka Gaur, Amita Aggarwal, Rakesh Aggarwal
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Gastroenterology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12876-018-0819-6
_version_ 1818497329064312832
author Ankita Singh
Aditya N. Sarangi
Amit Goel
Rajni Srivastava
Rajat Bhargava
Priyanka Gaur
Amita Aggarwal
Rakesh Aggarwal
author_facet Ankita Singh
Aditya N. Sarangi
Amit Goel
Rajni Srivastava
Rajat Bhargava
Priyanka Gaur
Amita Aggarwal
Rakesh Aggarwal
author_sort Ankita Singh
collection DOAJ
description Abstract Background Probiotics have been shown to be useful for the treatment of many disease conditions. These beneficial effects are believed to be mediated by change in the composition of gut microbiota and modulation of the host immune responses. However, the available data on the effect of probiotics on these parameters are quite limited. Methods We studied the composition of fecal microbiota, using 16S rRNA sequencing, and host immune responses in peripheral blood (plasma cytokine levels, T cell subsets and in vitro cytokine production after stimulation with anti-CD3/CD28 antibody or lipopolysaccharide) in a group of 14 healthy women at three time-points – before and after administration of a probiotic preparation (a capsule of VSL#3, each containing 112.5 billion freeze-dried bacterial cells belonging to 8 species, twice a day for 4 weeks), and 4-weeks after discontinuation of the probiotic administration. Results There was no change in the abundance of various bacterial taxa as well as in the alpha diversity of gut microbiota following administration of the probiotic, or following its discontinuation. Probiotic administration led to a reduction in the relative frequency of circulating Th17 cells, and in vitro production of cytokines in whole-blood cultures in response to lipopolysaccharide stimulation. However, it had no effect on the relative frequencies of Th1, Th2 and T regulatory cells among circulating peripheral blood mononuclear cells, on plasma cytokine levels and on in vitro production of cytokines by T cells. Conclusions We found that VSL#3 administration did not lead to any changes in gut flora, but led to a reduction in the frequency of Th17 cells and in the production of pro-inflammatory cytokine on lipopolysaccharide stimulation. These findings suggest that the beneficial anti-inflammatory effect of this preparation in patients with autoimmune and allergic disorders may be related to reduced production of monocyte-derived cytokines rather than to changes in the composition of gut microbiota. Trial registration NCT03330678, Date of registration 30th October 2017. Retrospectively registered.
first_indexed 2024-12-10T18:44:16Z
format Article
id doaj.art-d1654805b96b4ec7a5e46a2166201af9
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-10T18:44:16Z
publishDate 2018-06-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-d1654805b96b4ec7a5e46a2166201af92022-12-22T01:37:34ZengBMCBMC Gastroenterology1471-230X2018-06-0118111110.1186/s12876-018-0819-6Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot studyAnkita Singh0Aditya N. Sarangi1Amit Goel2Rajni Srivastava3Rajat Bhargava4Priyanka Gaur5Amita Aggarwal6Rakesh Aggarwal7Departments of Immunology, Sanjay Gandhi Postgraduate Institute of Medical SciencesGastroenterology, Sanjay Gandhi Postgraduate Institute of Medical SciencesGastroenterology, Sanjay Gandhi Postgraduate Institute of Medical SciencesDepartments of Immunology, Sanjay Gandhi Postgraduate Institute of Medical SciencesGastroenterology, Sanjay Gandhi Postgraduate Institute of Medical SciencesDepartments of Immunology, Sanjay Gandhi Postgraduate Institute of Medical SciencesDepartments of Immunology, Sanjay Gandhi Postgraduate Institute of Medical SciencesGastroenterology, Sanjay Gandhi Postgraduate Institute of Medical SciencesAbstract Background Probiotics have been shown to be useful for the treatment of many disease conditions. These beneficial effects are believed to be mediated by change in the composition of gut microbiota and modulation of the host immune responses. However, the available data on the effect of probiotics on these parameters are quite limited. Methods We studied the composition of fecal microbiota, using 16S rRNA sequencing, and host immune responses in peripheral blood (plasma cytokine levels, T cell subsets and in vitro cytokine production after stimulation with anti-CD3/CD28 antibody or lipopolysaccharide) in a group of 14 healthy women at three time-points – before and after administration of a probiotic preparation (a capsule of VSL#3, each containing 112.5 billion freeze-dried bacterial cells belonging to 8 species, twice a day for 4 weeks), and 4-weeks after discontinuation of the probiotic administration. Results There was no change in the abundance of various bacterial taxa as well as in the alpha diversity of gut microbiota following administration of the probiotic, or following its discontinuation. Probiotic administration led to a reduction in the relative frequency of circulating Th17 cells, and in vitro production of cytokines in whole-blood cultures in response to lipopolysaccharide stimulation. However, it had no effect on the relative frequencies of Th1, Th2 and T regulatory cells among circulating peripheral blood mononuclear cells, on plasma cytokine levels and on in vitro production of cytokines by T cells. Conclusions We found that VSL#3 administration did not lead to any changes in gut flora, but led to a reduction in the frequency of Th17 cells and in the production of pro-inflammatory cytokine on lipopolysaccharide stimulation. These findings suggest that the beneficial anti-inflammatory effect of this preparation in patients with autoimmune and allergic disorders may be related to reduced production of monocyte-derived cytokines rather than to changes in the composition of gut microbiota. Trial registration NCT03330678, Date of registration 30th October 2017. Retrospectively registered.http://link.springer.com/article/10.1186/s12876-018-0819-6ProbioticGut microbiomeImmune responseVSL#3Healthy women
spellingShingle Ankita Singh
Aditya N. Sarangi
Amit Goel
Rajni Srivastava
Rajat Bhargava
Priyanka Gaur
Amita Aggarwal
Rakesh Aggarwal
Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
BMC Gastroenterology
Probiotic
Gut microbiome
Immune response
VSL#3
Healthy women
title Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
title_full Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
title_fullStr Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
title_full_unstemmed Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
title_short Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
title_sort effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in india an open label single arm pilot study
topic Probiotic
Gut microbiome
Immune response
VSL#3
Healthy women
url http://link.springer.com/article/10.1186/s12876-018-0819-6
work_keys_str_mv AT ankitasingh effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT adityansarangi effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT amitgoel effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT rajnisrivastava effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT rajatbhargava effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT priyankagaur effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT amitaaggarwal effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy
AT rakeshaggarwal effectofadministrationofaprobioticpreparationongutmicrobiotaandimmuneresponseinhealthywomeninindiaanopenlabelsinglearmpilotstudy